125 related articles for article (PubMed ID: 296787)
1. Hepatotoxicity in the treatment of acute lymphoblastic leukaemia.
Topley JM; Benson J; Squier MV; Chessells JM
Med Pediatr Oncol; 1979; 7(4):393-9. PubMed ID: 296787
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate hepatotoxicity in children with leukemia.
McIntosh S; Davidson DL; O'Brien RT; Pearson HA
J Pediatr; 1977 Jun; 90(6):1019-21. PubMed ID: 870655
[TBL] [Abstract][Full Text] [Related]
3. Liver damage in children with acute leukaemia and non-Hodgkin's lymphoma on oral maintenance chemotherapy.
Parker D; Bate CM; Craft AW; Graham-Pole J; Malpas JS; Stansfeld AG
Cancer Chemother Pharmacol; 1980; 4(2):121-7. PubMed ID: 6930333
[TBL] [Abstract][Full Text] [Related]
4. Testicular histology after combination chemotherapy in childhood for acute lymphoblastic leukaemia.
Lendon M; Hann IM; Palmer MK; Shalet SM; Jones PH
Lancet; 1978 Aug; 2(8087):439-41. PubMed ID: 79804
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of hepatic function during maintenance therapy of acute lymphoblastic leukemia remission in children].
Mancini AF; Rosito P; Vecchi V; Vivarelli F; Faldella G; De Luca M
Minerva Pediatr; 1977 Nov; 29(36):2133-42. PubMed ID: 271760
[No Abstract] [Full Text] [Related]
6. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S
Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936
[TBL] [Abstract][Full Text] [Related]
7. Liver histology after current intensified therapy for childhood acute lymphoblastic leukemia: microvesicular fatty change and siderosis are the main findings.
Halonen P; Mattila J; Ruuska T; Salo MK; Mäkipernaa A
Med Pediatr Oncol; 2003 Mar; 40(3):148-54. PubMed ID: 12518342
[TBL] [Abstract][Full Text] [Related]
8. Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
Chessells JM; Durrant J; Hardy RM; Richards S
J Clin Oncol; 1986 Dec; 4(12):1758-64. PubMed ID: 3537216
[TBL] [Abstract][Full Text] [Related]
9. Erythrocyte concentrations of metabolites or cumulative doses of 6-mercaptopurine and methotrexate do not predict liver changes in children treated for acute lymphoblastic leukemia.
Halonen P; Mattila J; Mäkipernaa A; Ruuska T; Schmiegelow K
Pediatr Blood Cancer; 2006 Jun; 46(7):762-6. PubMed ID: 16395677
[TBL] [Abstract][Full Text] [Related]
10. Enteropathy complicating maintenance therapy in acute lymphoblastic leukaemia.
Lewis IJ; Mainwaring D; Martin J
Arch Dis Child; 1982 Sep; 57(9):663-7. PubMed ID: 6982027
[TBL] [Abstract][Full Text] [Related]
11. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group.
Koizumi S; Fujimoto T; Takeda T; Yatabe M; Utsumi J; Mimaya J; Ninomiya T; Yanai M
Cancer; 1988 Apr; 61(7):1292-300. PubMed ID: 3278798
[TBL] [Abstract][Full Text] [Related]
13. Excessive chemotherapy-related myelotoxicity in children with Down syndrome and acute lymphoblastic leukaemia.
Blatt J; Albo V; Prin W; Orlando S; Wollman M
Lancet; 1986 Oct; 2(8512):914. PubMed ID: 2876340
[No Abstract] [Full Text] [Related]
14. Transient acute hepatotoxicity of high-dose methotrexate therapy during childhood.
Weber BL; Tanyer G; Poplack DG; Reaman GH; Feusner JH; Miser JS; Bleyer WA
NCI Monogr; 1987; (5):207-12. PubMed ID: 3481038
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.
Br Med J; 1971 Oct; 4(5781):189-94. PubMed ID: 4940157
[TBL] [Abstract][Full Text] [Related]
16. Maintenance chemotherapy for childhood acute lymphoblastic leukaemia: better in the evening.
Rivard GE; Infante-Rivard C; Hoyoux C; Champagne J
Lancet; 1985 Dec; 2(8467):1264-6. PubMed ID: 2866334
[TBL] [Abstract][Full Text] [Related]
17. Refractory acute leukaemia in adults treated with sequential colaspase and high-dose methotrexate.
Yap BS; McCredie KB; Benjamin RS; Bodey GP; Freireich EJ
Br Med J; 1978 Sep; 2(6140):791-3. PubMed ID: 279387
[TBL] [Abstract][Full Text] [Related]
18. Hepatic ultrastructure in leukemic children treated with methotrexate and 6-mercaptopurine.
Harb JM; Werlin SL; Camitta BM; Oechler H; Kamin BA; Blank EL
Am J Pediatr Hematol Oncol; 1983; 5(4):323-31. PubMed ID: 6686921
[TBL] [Abstract][Full Text] [Related]
19. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
Lanse SB; Arnold GL; Gowans JD; Kaplan MM
Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
[TBL] [Abstract][Full Text] [Related]
20. Jejunal crypt cell abnormalities associated with methotrexate treatment in children with acute lymphoblastic leukaemia.
Pinkerton CR; Cameron CH; Sloan JM; Glasgow JF; Gwevava NJ
J Clin Pathol; 1982 Nov; 35(11):1272-7. PubMed ID: 6958682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
